Imperial College London
Dr Kikkeri Naresh

DrKikkeriNaresh

Faculty of Medicine, Department of Immunology and Inflammation

Visiting Professor
 
 
 
//

Contact

 

+44 (0)20 3313 3969k.naresh

 
 
//

Location

 

Office 6, Building 541, G-BlockHammersmith HospitalHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Alaggio:2022:10.1038/s41375-022-01620-2,
author = {Alaggio, R and Amador, C and Anagnostopoulos, I and Attygalle, AD and Araujo, IBDO and Berti, E and Bhagat, G and Borges, AM and Boyer, D and Calaminici, M and Chadburn, A and Chan, JKC and Cheuk, W and Chng, W-J and Choi, JK and Chuang, S-S and Coupland, SE and Czader, M and Dave, SS and de, Jong D and Du, M-Q and Elenitoba-Johnson, KS and Ferry, J and Geyer, J and Gratzinger, D and Guitart, J and Gujral, S and Harris, M and Harrison, CJ and Hartmann, S and Hochhaus, A and Jansen, PM and Karube, K and Kempf, W and Khoury, J and Kimura, H and Klapper, W and Kovach, AE and Kumar, S and Lazar, AJ and Lazzi, S and Leoncini, L and Leung, N and Leventaki, V and Li, X-Q and Lim, MS and Liu, W-P and Louissaint, A and Marcogliese, A and Medeiros, LJ and Michal, M and Miranda, RN and Mitteldorf, C and Montes-Moreno, S and Morice, W and Nardi, V and Naresh, KN and Natkunam, Y and Ng, S-B and Oschlies, I and Ott, G and Parrens, M and Pulitzer, M and Rajkumar, SV and Rawstron, AC and Rech, K and R},
doi = {10.1038/s41375-022-01620-2},
journal = {Leukemia},
pages = {1720--1748},
title = {The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms},
url = {http://dx.doi.org/10.1038/s41375-022-01620-2},
volume = {36},
year = {2022}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - We herein present an overview of the upcoming 5th edition of the World Health Organization Classification of Haematolymphoid Tumours focussing on lymphoid neoplasms. Myeloid and histiocytic neoplasms will be presented in a separate accompanying article. Besides listing the entities of the classification, we highlight and explain changes from the revised 4th edition. These include reorganization of entities by a hierarchical system as is adopted throughout the 5th edition of the WHO classification of tumours of all organ systems, modification of nomenclature for some entities, revision of diagnostic criteria or subtypes, deletion of certain entities, and introduction of new entities, as well as inclusion of tumour-like lesions, mesenchymal lesions specific to lymph node and spleen, and germline predisposition syndromes associated with the lymphoid neoplasms.
AU  - Alaggio,R
AU  - Amador,C
AU  - Anagnostopoulos,I
AU  - Attygalle,AD
AU  - Araujo,IBDO
AU  - Berti,E
AU  - Bhagat,G
AU  - Borges,AM
AU  - Boyer,D
AU  - Calaminici,M
AU  - Chadburn,A
AU  - Chan,JKC
AU  - Cheuk,W
AU  - Chng,W-J
AU  - Choi,JK
AU  - Chuang,S-S
AU  - Coupland,SE
AU  - Czader,M
AU  - Dave,SS
AU  - de,Jong D
AU  - Du,M-Q
AU  - Elenitoba-Johnson,KS
AU  - Ferry,J
AU  - Geyer,J
AU  - Gratzinger,D
AU  - Guitart,J
AU  - Gujral,S
AU  - Harris,M
AU  - Harrison,CJ
AU  - Hartmann,S
AU  - Hochhaus,A
AU  - Jansen,PM
AU  - Karube,K
AU  - Kempf,W
AU  - Khoury,J
AU  - Kimura,H
AU  - Klapper,W
AU  - Kovach,AE
AU  - Kumar,S
AU  - Lazar,AJ
AU  - Lazzi,S
AU  - Leoncini,L
AU  - Leung,N
AU  - Leventaki,V
AU  - Li,X-Q
AU  - Lim,MS
AU  - Liu,W-P
AU  - Louissaint,A
AU  - Marcogliese,A
AU  - Medeiros,LJ
AU  - Michal,M
AU  - Miranda,RN
AU  - Mitteldorf,C
AU  - Montes-Moreno,S
AU  - Morice,W
AU  - Nardi,V
AU  - Naresh,KN
AU  - Natkunam,Y
AU  - Ng,S-B
AU  - Oschlies,I
AU  - Ott,G
AU  - Parrens,M
AU  - Pulitzer,M
AU  - Rajkumar,SV
AU  - Rawstron,AC
AU  - Rech,K
AU  - Rosenwald,A
AU  - Said,J
AU  - Sarkozy,C
AU  - Sayed,S
AU  - Saygin,C
AU  - Schuh,A
AU  - Sewell,W
AU  - Siebert,R
AU  - Sohani,AR
AU  - Tooze,R
AU  - Traverse-Glehen,A
AU  - Vega,F
AU  - Vergier,B
AU  - Wechalekar,AD
AU  - Wood,B
AU  - Xerri,L
AU  - Xiao,W
DO  - 10.1038/s41375-022-01620-2
EP  - 1748
PY  - 2022///
SN  - 0887-6924
SP  - 1720
TI  - The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms
T2  - Leukemia
UR  - http://dx.doi.org/10.1038/s41375-022-01620-2
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000814462100003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
UR  - https://www.nature.com/articles/s41375-022-01620-2
UR  - http://hdl.handle.net/10044/1/100567
VL  - 36
ER  -
Download